Donoghue Forlines LLC Viatris Inc Transaction History

Donoghue Forlines LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.32 - $12.13 $458,837 - $539,311	44,461 Added 76.49%	102,585 $1.19 Million
Q2 2024 Aug 06, 2024	BUY	$10.05 - $12.02 $69,636 - $83,286	6,929 Added 13.53%	58,124 $617,000
Q1 2024 May 07, 2024	SELL	$11.27 - $13.53 $171,529 - $205,926	-15,220 Reduced 22.92%	51,195 $611,000
Q4 2023 Feb 07, 2024	BUY	$8.77 - $10.85 $582,459 - $720,602	66,415 New	66,415 $719,000
Q1 2023 May 08, 2023	SELL	$9.2 - $12.26 $454,590 - $605,791	-49,412 Reduced 55.21%	40,091 $385,000
Q4 2022 Feb 08, 2023	BUY	$8.72 - $11.56 $354,459 - $469,902	40,649 Added 83.21%	89,503 $996,000
Q3 2022 Nov 07, 2022	BUY	$8.48 - $11.13 $414,281 - $543,745	48,854 New	48,854 $416,000

1,136

989M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $9.18B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.